Drug-associated paronychia: Pharmacovigilance signals from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) and the Canada Vigilance Adverse Reaction Database (CVARD)

J Am Acad Dermatol. 2026 Feb 17:S0190-9622(26)00260-4. doi: 10.1016/j.jaad.2026.02.046. Online ahead of print.

Authors

Duc V Le¹, Hue T T Tran¹, David A Wetter², Giang H Nguyen³

Affiliations

¹ Department of Dermatology, Mayo Clinic, Rochester, Minnesota; National Hospital of Dermatology and Venereology, Hanoi, Vietnam.
² Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
³ Department of Dermatology, Mayo Clinic, Rochester, Minnesota. Electronic address: nguyen.giang2@mayo.edu.

PMID: 41713582
DOI: 10.1016/j.jaad.2026.02.046

No abstract available

Keywords: FAERS; adverse events; drug-associated paronychia; paronychia; pharmacovigilance.